Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.
J Vasc Interv Radiol. 2011 Apr;22(4):497-502. doi: 10.1016/j.jvir.2011.01.426. Epub 2011 Mar 5.
To evaluate the safety and effectiveness of a new embolization technique named the 1-2-3 protocol to achieve complete necrosis of adenomyosis after uterine artery embolization (UAE) and to determine predictive factors on magnetic resonance (MR) imaging.
A total of 40 patients with adenomyosis without leiomyomas diagnosed on MR imaging were prospectively enrolled. They were subdivided into three categories based on MR signal intensity (SI) of the adenomyosis on T2-weighted imaging: dark, low, and heterogeneous SI or SI equal to that of the myometrium. Nonspherical polyvinyl alcohol particles were used in all cases, beginning with 150-250-μm particles and progressively increasing to 250-355-μm and then 355-500-μm particles to the endpoint. Patients were assessed for extent of devascularization on MR imaging and for durability of symptom control.
Of the 40 patients who underwent UAE for adenomyosis with the 1-2-3 protocol, 33 (82.5%) exhibited complete necrosis of adenomyosis. All six patients with dark SI of adenomyosis exhibited complete necrosis (100%). Of the 28 patients with low SI of adenomyosis, 25 (89.3%) showed complete necrosis. Among the six patients with heterogenous SI or SI equal to that of myometrium, only two (33.3%) showed complete necrosis (P < .01). Of 16 patients with complete necrosis followed up to 18 months, none reported recurrent menorrhagia. Of the five patients without necrosis, only one had no symptoms at 18 months.
UAE with the 1-2-3 protocol is safe and highly effective to achieve complete necrosis of adenomyosis. Dark SI of adenomyosis is the most favorable predictive factor for UAE on MR imaging, followed by low SI. Heterogenous SI or SI equal to that of the myometrium is an unfavorable predictive factor.
评估一种新的栓塞技术——1-2-3 方案,用于实现子宫动脉栓塞术(UAE)后子宫腺肌病的完全坏死,并确定磁共振成像(MR)上的预测因素。
前瞻性纳入 40 例经 MR 成像诊断为腺肌病而无子宫肌瘤的患者。根据 T2 加权成像上腺肌病的信号强度(SI),将其分为三类:暗、低和不均匀 SI 或与子宫肌层相等的 SI。所有病例均使用非球形聚乙烯醇颗粒,从 150-250μm 颗粒开始,逐渐增加至 250-355μm 和 355-500μm 颗粒,直至达到终点。患者在 MR 成像上评估血管化程度,并评估症状控制的持久性。
在接受 UAE 治疗的 40 例腺肌病患者中,33 例(82.5%)腺肌病完全坏死。腺肌病暗 SI 的 6 例患者均完全坏死(100%)。28 例低 SI 腺肌病患者中,25 例(89.3%)完全坏死。6 例腺肌病呈不均匀 SI 或与子宫肌层等 SI 的患者中,仅 2 例(33.3%)完全坏死(P<.01)。16 例完全坏死并随访 18 个月的患者中,无 1 例出现复发性月经过多。5 例未坏死的患者中,仅有 1 例在 18 个月时无症状。
1-2-3 方案的 UAE 是安全且非常有效的,可实现腺肌病的完全坏死。腺肌病暗 SI 是 UAE 最有利的 MR 成像预测因素,其次是低 SI。不均匀 SI 或与子宫肌层等 SI 是不利的预测因素。